Matthew Yeowart
Lawyers
Filters
HNI $2.2 billion acquisition of Steelcase
We are advising HNI on the transaction
Mavenir Systems comprehensive out-of-court debt recapitalization
We advised an ad hoc group of term loan lenders on the transaction
GSK agreements with Hengrui Pharma to develop up to 12 innovative medicines
We are advising GSK on the transaction
SS&C Technologies $1.03 billion acquisition of Calastone
We are advising SS&C Technologies on the transaction
Mitel emerges from chapter 11
We advised an ad hoc group of secured lenders in connection with Mitel’s chapter 11 proceedings
Fever acquisition of DICE
We are advising Fever on the acquisition
CoreWeave acquisition of Weights and Biases
We are advising CoreWeave on the transaction
GSK strategic alliance with Vesalius Therapeutics
We advised GSK on the transaction
ATSG $3.1 billion acquisition by Stonepeak
We are advising Air Transport Services Group on its going-private transaction
Nippon Paint Holdings $2.3 billion AOC acquisition
We are advising Nippon Paint on the acquisition